Dutton adds new medicines to Pharmaceutical Benefits Scheme

SUFFERERS of cystic fibrosis and a rare disease that attacks organ function will be able to access cheaper treatments from December.

Health Minister Peter Dutton today announced two new medicines for the diseases would be listed on the Pharmaceutical Benefits Scheme.

The medicines, Kalydeco, for cystic fibrosis and Soliris, or atypical haemolytic uraemic syndrome, will be listed from December 1.

Mr Dutton said listing the Kalydeco medicine would help more than 250 Australians affected by cystic fibrosis, saving about $300,000 a year for each patient.

He also said listing the Soliris medicine, for the ultra-rare aHUS condition, would help sufferers and their families meet the $500,000 annual cost of that medicine.

Listing both medicines on the PBS will cost the government about $238 million over the next four years, the drug manufacturers will have to meet some conditions prior to the listing.
- APN NEWSDESK
 



Drivers urged to slow down to save our lives

Premium Content Drivers urged to slow down to save our lives

Regional NSW over-represented in road toll statistics, with two-thirds of road...

UPDATE: Traffic chaos near Big Banana

Premium Content UPDATE: Traffic chaos near Big Banana

A crash near the Big Banana caused traffic chaos this evening.

Push ahead with plans or cop an extra $38m Crs warned

Premium Content Push ahead with plans or cop an extra $38m Crs warned

Council could face extra costs of $38 million over 20 years.